Barron's Weekend Stock Picks: Uber Joins The S&P 500, Schwab Rebounds And What's Next for Johnson & Johnson?
Barron's Weekend Stock Picks: Uber Joins The S&P 500, Schwab Rebounds And What's Next for Johnson & Johnson?
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.
In "Uber Joins the S&P 500. Here's Which Other Stocks Did—and Which Ones Were Removed," Andrew Bary writes that Uber Technologies Inc's (NYSE:UBER) addition to the S&P 500 comes after the company's recent profitability and makes it the largest inclusion of a U.S. company by market capitalization that was not previously in the index.
本辛加回顾了本周末巴伦周末报道的热门报道。以下是投资者需要阅读的文章。
在 “优步加入标准普尔500指数” 中。以下是其他哪些股票确实如此，哪些股票被移除。” 安德鲁·巴里写道，Uber Technologies Inc（纽约证券交易所代码：UBER）加入标准普尔500指数是在该公司最近实现盈利之后出现的，按市值计算，这是该指数中前所未有的最大一家。
In "Phillips 66 Stock Could Rise More on Activist Investor's Prodding," Carleton English writes that Elliott Management's $1 billion stake in multinational energy company Phillips 66 (NYSE:PSX) seeks changes for a potential 75% stock increase, challenging CEO Mark Lashier's plans as Wall Street supports the activist's push.
卡尔顿·英吉利斯在《激进投资者的推动下，菲利普斯66股票可能进一步上涨》中写道，埃利奥特管理公司持有的跨国能源公司菲利普斯66（纽约证券交易所代码：PSX）的10亿美元股份寻求变动，以实现股价可能上涨75％，这挑战了首席执行官马克·拉希尔的计划，因为华尔街支持该激进分子的推动。
In "Schwab's Stock Rebounds. Why It Could Gain More Next Year," Andrew Welsch writes that Charles Schwab's (NYSE:SCHW) stock rose around 12% this past week despite challenges, driven by optimistic outlooks by analysts.
在 “施瓦布的股票反弹” 中。为什么明年能涨幅更大。” 安德鲁·韦尔施写道，在分析师乐观前景的推动下，尽管面临挑战，但查尔斯·施瓦布（纽约证券交易所代码：SCHW）的股票在过去一周仍上涨了约12％。
In "Apple Stock Has Tough Decembers. Why This Time Could Be Different," Angela Palumbo writes that, while December historically shows weak performance for Apple Inc (NASDAQ:AAPL) stock, this year brings hope with high holiday expectations and improved supply conditions from the previous year.
在 “苹果股票十二月表现艰难” 中。为什么这次可能会有所不同。” 安吉拉·帕伦博写道，尽管12月份苹果公司（纳斯达克股票代码：AAPL）的股票历来表现疲软，但今年带来了希望，假日预期很高，供应条件也比去年有所改善。
In "Johnson & Johnson Stock Gains a Bull Ahead of Analyst Day," Emily Dattilo writes that UBS analysts upgraded Johnson & Johnson (NYSE:JNJ) to "Buy," citing a positive outlook for its Innovative Medicine business and MedTech growth in line with the market.
艾米丽·达蒂洛在 “分析师日前强生股票上涨” 中写道，瑞银分析师将强生（纽约证券交易所代码：JNJ）上调至 “买入”，理由是其创新医学业务前景乐观，医疗科技增长与市场一致。
Read Next: From Bearish To Bullish: Major Analysts Predict US Stock Market's Performance In 2024
继续阅读：从看跌到看涨：主要分析师预测美国股市在2024年的表现
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
该内容部分是在人工智能工具的帮助下制作的，并由Benzinga编辑审查和发布。
Photo: Shutterstock
照片：Shutterstock